Sudeep Pharma Shares Plunge 6% as Q2 Net Profit Dips to Rs 46 Crore

• Newly-listed Sudeep Pharma shares dropped over 6% on December 22 after Q2 FY26 results.
• Consolidated net profit fell 6% YoY to Rs 45.74 crore in Q2 FY26, from Rs 48.75 crore in Q2 FY25.
• Revenue from operations rose 9% YoY to Rs 162.67 crore; however, expenses grew 27% and EBITDA margin contracted.
• Sudeep Pharma MD Sujit Bhayani expressed confidence in long-term growth despite the Q2 dip.
• The stock is down nearly 12% from its listing price of Rs 730 but still up 9% from its IPO price of Rs 593.

Why It Matters: Sudeep Pharma's Q2 profit dip led to a share drop, but management remains optimistic on growth.